Clark Kyle
SEE REMARKS, Director
8 filings on record here, covering BETA, FGNX, EVMN. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Sell | BETA | BETA Technologies, Inc. | $348,808 |
| Sell | BETA | BETA Technologies, Inc. | $385,252 |
| Sell | BETA | BETA Technologies, Inc. | $415,937 |
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-10
| Buy | EVMN | Evommune, Inc. | $13,260 |
CORPORATEFiled 2026-07-06
| Sell | BETA | BETA Technologies, Inc. | $261,128 |
| Sell | BETA | BETA Technologies, Inc. | $268,938 |
CORPORATEFiled 2026-07-01
| Sell | BETA | BETA Technologies, Inc. | $245,754 |
| Sell | BETA | BETA Technologies, Inc. | $248,937 |
CORPORATEFiled 2026-06-23
| Sell | BETA | BETA Technologies, Inc. | $236,739 |
| Sell | BETA | BETA Technologies, Inc. | $236,068 |
| Sell | BETA | BETA Technologies, Inc. | $240,128 |
CORPORATEFiled 2026-06-23
| Sell | BETA | BETA Technologies, Inc. | $236,739 |
| Sell | BETA | BETA Technologies, Inc. | $236,068 |
| Sell | BETA | BETA Technologies, Inc. | $240,128 |
CORPORATEFiled 2026-06-18
| Sell | BETA | BETA Technologies, Inc. | $238,340 |
| Sell | BETA | BETA Technologies, Inc. | $240,801 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.